Page last updated: 2024-12-07
n-(3-pyridyl)-3-phenylsuccinimide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
N-(3-pyridyl)-3-phenylsuccinimide: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 130502 |
MeSH ID | M0175776 |
Synonyms (11)
Synonym |
---|
3-phenyl-1-(3-pyridinyl)-2,5-pyrrolidinedione |
brn 0410747 |
2,5-pyrrolidinedione, 3-phenyl-1-(3-pyridinyl)- |
alpha-phenylsuccinic acid n-(3-pyridyl)imide |
n-(3-pyridyl)-3-phenylsuccinimide |
125709-33-3 |
69537-45-7 |
3-phenyl-1-(pyridin-3-yl)pyrrolidine-2,5-dione |
3-phenyl-1-pyridin-3-ylpyrrolidine-2,5-dione |
5-22-09-00027 (beilstein handbook reference) |
DTXSID10925235 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (16)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 1 (6.25) | 29.6817 |
2010's | 1 (6.25) | 24.3611 |
2020's | 13 (81.25) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 13.22
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.22) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (5.56%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 17 (94.44%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |